CAS 126-27-2

Oxethazaine

Description:

Oxethazaine, with the CAS number 126-27-2, is a local anesthetic agent primarily used for its analgesic properties in topical applications. It is characterized by its ability to provide temporary relief from pain and discomfort, particularly in the oral cavity and gastrointestinal tract. Chemically, oxethazaine belongs to the class of compounds known as benzoic acid derivatives, and it features a unique structure that allows it to penetrate biological membranes effectively. This compound is typically formulated in various topical preparations, including gels and ointments, and is often combined with other active ingredients to enhance its efficacy. Oxethazaine works by blocking sodium channels, thereby inhibiting the transmission of nerve impulses in the affected area. Its onset of action is relatively rapid, making it suitable for acute pain management. However, like all medications, it should be used with caution, as it may cause side effects or allergic reactions in some individuals. Proper dosage and application guidelines should always be followed to ensure safety and effectiveness.

Formula: C₂₈H₄₁N₃O₃

InChI: InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3

InChI key: InChIKey=FTLDJPRFCGDUFH-UHFFFAOYSA-N

SMILES: C(N(C(CN(CC(N(C(CC1=CC=CC=C1)(C)C)C)=O)CCO)=O)C)(CC2=CC=CC=C2)(C)C

Synonyms:

• 2,2'-[(2-hydroxyethyl)imino]bis[N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide]
• 2,2′-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]
• 2,2′-[(2-Hydroxyethyl)imino]bis[N-(α,α-dimethylphenethyl)-N-methylacetamide]
• 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol
• 2-[2-Hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide
• Acetamide, 2,2′-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-
• Acetamide, 2,2′-[(2-hydroxyethyl)imino]bis[N-(α,α-dimethylphenethyl)-N-methyl-
• Betalgil
• Fh 099
• Mucoxin
• N,N-bis(alpha,alpha-dimethylphenethyl)-N,N-dimethyl-2,2-(2-hydroxyethylimino)di(acetamide)
• Oxaine
• Oxetacaine
• Storocain
• Storocaine
• Topicain

Oxetacaine

CAS: 126-27-2

Color and Shape: Neat

Ref: 61-FOR1981.00

2-[(2-hydroxyethyl)({[methyl(2-methyl-1-phenylpropan-2-yl)carbamoyl]methyl})amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide

CAS: 126-27-2

Formula: C₂₈H₄₁N₃O₃

Purity: 95%

Color and Shape: Solid

Molecular weight: 467.6434

Ref: IN-DA000QO3

Oxethazaine

CAS: 126-27-2

Formula: C₂₈H₄₁N₃O₃

Color and Shape: White To Off-White Solid

Molecular weight: 467.66

Ref: 4Z-O-141

Oxethazaine

CAS: 126-27-2

Oxethazaine

Purity: ≥98%

Molecular weight: 467.64g/mol

Ref: 54-BUP11768

Oxetacaine

CAS: 126-27-2

Formula: C₂₈H₄₁N₃O₃

Color and Shape: Neat

Molecular weight: 467.64

Ref: 86-MM1981.00

Oxethazaine

CAS: 126-27-2

Oxethazaine (Oxetacaine), a topical anesthetic, is used to prevent acid-induced esophageal pain.

Formula: C₂₈H₄₁N₃O₃

Purity: 99.875% - 99.94%

Color and Shape: Physical Description White Powder (Ntp 1992)

Molecular weight: 467.64

Ref: TM-T0044

Oxethazaine

CAS: 126-27-2

Oxethazaine is a drug that has been used to treat bowel disease and other diseases of the stomach and intestines. It belongs to the group of drugs called anticholinergic agents, which block the passage of nerve impulses in the intestine. The drug is also known for its ability to reduce inflammation and inhibit pain caused by autoimmune diseases. Oxethazaine is a potent inhibitor of fatty acid biosynthesis, which may be responsible for its therapeutic properties. This drug has not been extensively studied for its toxicity or pharmacokinetic properties.

Formula: C₂₈H₄₁N₃O₃

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 467.64 g/mol

Ref: 3D-FO26625

Oxethazaine

Controlled Product

CAS: 126-27-2

Applications A potent local anesthetic that is active even in acidic conditions. It is used (usually in combination with an antacid) for the relief of pain associated with peptic ulcer disease or esophagitis.
References Detrain, M. et al.: Acta. Gastro-Enterol. Belg., 28, 360 (1965); Barbezat, G.O. et al.: Scand. J. Gastroenterol., 13, 321 (1978); Masuda, Y. et al.: Biochem. Pharmacol., 64, 677 (2002);

Formula: C₂₈H₄₁N₃O₃

Color and Shape: Neat

Molecular weight: 467.64

Ref: TR-O846600